National and Kapodistrian University of Athens
Μοριακός χαρακτηρισμός του φαινοτύπου μεθυλίωσης των νησίδων CpG (CIMP) στο σποραδικό καρκίνο του παχέος εντέρου
Abstract
dc:descriptionDNA methylation is important for normal development and cancer pathology. Current notion postulates that DNA methylation of regulatory sequences contributes to carcinogenesis by conferring transcriptional silencing of tumor suppressor genes. Both methylation and demethylation is employed to build up the patterns of genomic methylation that characterize each cell type as a molecular fingerprint. Demethylation is occurring in regulatory sequences while DNA methylation is enriched in regulatory, coding and repeat regions alike. Dnmts the enzymes building up the genomic methylation patterns have being recognized as dual specificity enzymes, acting either as DNA methyltransferases which methylate cytosines in the context of CpG dinucleotides or as deaminases by converting methylated cytosines to thymines. These thymines are recognized in DNA mismatches and are replaced by cytosines via DNA repair pathways. Cancer cells as opposed to normal cells, present abnormal DNA methylation, summarized into hypermethylation of transcription regulatory elements and hypomethylation of the rest of the genome. This situation is best characterized in sporadic colorectal cancers and is called CpG Island Methylator Phenotype (CIMP). CIMP Iis correlated with a common BRAF mutation namely, BRAFV600E. Although, the molecular mechanism of CIMP is currently unknown, a deregulation of Dnmts is implied. Our research reveals that under physiologic conditions Dnmt3a1 exhibits dual enzymatic specificity in mESCs and that its deregulation affects gene expression during mESC differentiation via retinoic acid treatment. More specifically, Dnmt3a1 is responsible for the permanent silencing of pluripotency genes -that are additionally found into chromosomal clusters- and for the efficient expression of a distinct set of genes which are important for organism’s growth and welfare. Moreover, Dnmt3a1 plays a crucial role in maintaining the Imprint DNA methylation in mESCs. Additionally, we find that Dnmt3a1 and the DNA methylation machinery is differentially targeted by wt and mutant BRAFV600E proteins. In light of our findings, we propose that CIMP pathology is directly related to the deregulation of the equilibrium between DNA methylation and cytidine deamination. To resolve this, an experimental system based on mouse colon adult stem cells and samples from CIMP cancer human biopsies is needed. This hypothesis was not further investigated in the present work, due to lack of biological samples.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kotini, Andriana
- Κοτίνη, Ανδριάνα
Subjects
dc:subject × 20- Μεθυλίωση
- Μεταγραφή
- Εντυπώμενα γονίδια
- DNA μεθυλοτρανσφεράσες
- Φαινότυπος μεθυλίωσης νησίδων CpG
- Καρκίνος παχέος εντέρου
- Απομεθυλίωση
- Εμβρυϊκά βλαστικά κύτταρα
- Methylation
- Transcription
- Imrinted genes
- DNA methyltransferases
- CpG Island Methylator Phenotype
- Colorectal cancer
- Demethylation
- Embryonic stem cells
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27791